Diabetes Ketoacidosis - CTV3 (DKA - unspecific)
Codelist metadata
- Coding system
- Pseudo BNF
- Coding system release
- unknown
- Author
- Brian MacKenna
- Codelist ID
- user/brian-mackenna/diabetes-ketoacidosis-ctv3-dka-unspecific
- Version ID
- 10edca56
Medication codelists can quickly become outdated and may not be
suitable for reuse. The
dictionary of medicines and devices
is updated weekly and
BNF codes
are updated monthly. Please check carefully for any new medicines
and codes before reusing this
codelist, or
create your own.
About
No metadata has been provided for this codelist.
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
| code | term |
|---|---|
| 0208020Y0 | Rivaroxaban |
This page shows the search terms that were used to build the codelist. Concepts that match the search terms, but which were excluded, are in faint grey.
rivaroxaban
Included 1 out of 13 matching concepts.
Show matching concepts
-
Rivaroxaban (
0208020Y0AA) -
Rivaroxaban (
0208020Y0) -
Rivaroxaban 10mg tablets (
0208020Y0AAAAAA) -
Rivaroxaban 15mg tablets (
0208020Y0AAABAB) -
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets (
0208020Y0AAAEAE) -
Rivaroxaban 2.5mg tablets (
0208020Y0AAADAD) -
Rivaroxaban 20mg tablets (
0208020Y0AAACAC) -
Xarelto (
0208020Y0BB) -
Xarelto 10mg tablets (
0208020Y0BBAAAA) -
Xarelto 15mg / 20mg treatment initiation pack (
0208020Y0BBAEAE) -
Xarelto 15mg tablets (
0208020Y0BBABAB) -
Xarelto 2.5mg tablets (
0208020Y0BBADAD) -
Xarelto 20mg tablets (
0208020Y0BBACAC)